OncoSec Medical Incorporated Aktie News
0,00 $
0,00 %
Nasdaq,
Mi, 15.05.2024
tracken
OncoSec Medical Incorporated Aktie News
Neutral
PRNewsWire
●
etwa ein Jahr alt
EWING, N.J. and SAN DIEGO , May 18, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,408,384 shar...
Positiv
PennyStocks
●
etwa ein Jahr alt
Hot penny stocks with big news this week. The post 3 Top Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Neutral
PRNewsWire
●
etwa ein Jahr alt
EWING, N.J. and SAN DIEGO , May 16, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced that it has entered into a definitive agreement for the purchase and sale of an agg...
Neutral
PRNewsWire
●
etwa ein Jahr alt
EWING, N.J. and SAN DIEGO , April 27, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced the receipt of $3.49 million in tax credit certificates from the New Jersey Economic D...
Neutral
PRNewsWire
●
etwa ein Jahr alt
EWING, N.J. and SAN DIEGO , April 11, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,582,932 sh...
Neutral
PRNewsWire
●
etwa ein Jahr alt
EWING, N.J. and SAN DIEGO , April 10, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced that it has entered into a definitive agreement for the purchase and sale of an ag...
Positiv
PennyStocks
●
etwa ein Jahr alt
Use these tips for avoiding common penny stocks The post Avoid Common Penny Stocks Trading Mistakes With These Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Negativ
InvestorPlace
●
mehr als ein Jahr alt
OncoSec Medical (NASDAQ: ONCS ) stock is falling on Thursday after the company revealed details of a stock offering. The biggest news from the company's prospectus is warrants of its stock having an exercise price of $2.02 per share.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
